Match Document Document Title Score
US20070112593 Selection system, dispensing system and treatment with a one-a-day combination pill for hypertension, hypercholesterolemia, hypertriglyceridemia and anti-platelet treatment  
The present invention relates to a selection system, a dispensing system and a process using a matrix enabling a physician to select one of the plurality of one-a-day combinatory pills. The system...
56
9101637 Methods of treating inflammation with compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity  
A novel pharmaceutical composition is provided by which nonsteroidal anti-inflammatory drugs (NSAIDs) are added directly to phospholipid-containing oil such as lecithin oils or to a bio-compatible...
56
4016268 Method of combatting gastric ulceration  
Bismuth subsalicylate co-administered with anti-inflammatory drugs combats gastric ulceration associated with such drugs.
56
US20020088737 Emergency pill dispenser  
The present invention provides a dispensing unit with a sealed enclosure containing a pill or pills which is provided by a cover attached to a flat base portion. The flat base portion is attached...
55
6471063 Emergency pill dispenser  
The present invention provides a dispensing unit with a sealed enclosure containing a pill or pills which is provided by a cover attached to a flat base portion. The flat base portion is attached...
55
7927613 Pharmaceutical co-crystal compositions  
A pharmaceutical composition comprising a co-crystal of an API and a co-crystal former; wherein the API has at least one functional group selected from ether, thioether, alcohol, thiol, aldehyde,...
55
US20090131376 PROCESS FOR THE MODIFICATION OF THE SOLID STATE OF A COMPOUND AND CO-AMORPHOUS COMPOSITIONS PRODUCED WITH SAME  
The invention provides a process for preparing non-crystalline organic compositions and non-crystalline, co-amorphous blends of organic compounds.
55
US20150272968 EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF  
Methods and compositions for reducing the frequency of urination are disclosed. One method comprises administering to a subject in need thereof an effective amount of a pharmaceutical composition...
55
4948588 Percutaneous absorption accelerator and preparation containing same  
A percutaneous absorption accelerator and a percutaneous absorbent preparation containing the same and, more particularly, a percutaneous absorption accelerator containing either derivatives of...
55
7812039 Drugs for chronic pains  
Nitro-oxyderivative compounds or salts thereof having the following general formula (I): A-(B)b0-(C)o0-N02 wherein: c0 is an integer and is 0 or 1, b0 is an integer and is 0 or 1, A=R-TI-, wherein...
55
US20170209585 HIGH PENETRATION COMPOSITIONS AND USES THEREOF  
The present invention relates to compositions and uses of novel high penetration compositions or high penetration prodrugs (HPP), in particular HPPs for non-steroidal anti-inflammatory agents...
54
US20050119160 Methods and reagents for the treatment of immunoinflammatory disorders  
The invention features a method for treating a patient diagnosed with, or at risk of developing, an immunoinflammatory disorder by administering to the patient a tetra-substituted...
54
US20080020065 Rapid-melt compositions, methods of making same and method of using same  
A novel rapid-melt composition, including methods of making the same, and methods of using the same for the delivery of prophylactic and therapeutic active materials to a mammal. The rapid-melt...
54
US20030064970 Compounds and therapies for the prevention of vascular and non-vascular pathologies  
The invention provides a method of treating a mammal having, or at risk of, an indication associated with a TGF-beta deficiency comprising administering one or more agents that is effective to...
54
5353547 Water activated hatch closure  
A closure assembly and strut for a pivoting closure which automatically operates to close the closure when rain begins to fall. The closure assembly is provided with two pivoting arms which, when...
54
US20150366817 DELAYED-RELEASE FORMULATIONS, METHODS OF MAKING AND USE THEREOF  
Compositions for reducing the frequency of urination and methods of manufacture of the compositions are disclosed. One method of manufacture include the steps of forming a first mixture comprising...
54
US20130203668 PHARMACEUTICAL COMPOSITION COMPRISING ANTIPLATELET AGENTS AND AN ERYTHROPOIESIS STIMULATING AGENT  
A composition comprising suitable anti-platelet agent/agents and the erythropoiesis stimulating agent for the treatment and improvement of kidney function is described. The combination also...
53
US20080207724 Use of Inhibitors of Histone Deacteylases in Combination With Compounds Acting as Nsaid for the Therapy of Human Diseases  
The present invention relates to the medical use of compounds acting as inhibitors of enzymes having histone deacetylase activity in conditions where their combination with compounds known as...
53
10329618 Diagnostic markers for platelet function and methods of use  
Disclosed herein are biomarkers of platelet function and methods for assessing platelet function in response to anti-platelet therapy and for determining a prognosis, diagnosis, or risk...
53
US20180078569 KITS FOR INDENTIFYING AND TREATING SUBJECTS RESISTANT TO ACETYL SALICYLIC ACID  
In alternative embodiments, the invention provides compositions and methods for overcoming or diminishing or preventing Growth Factor Inhibitor resistance in a cell, or, a method for increasing...
53
8445011 Delayed-release formulation for reducing the frequency of urination and method of use thereof  
Methods and compositions for reducing the frequency of urination are disclosed. One method comprises administering to a subject in need thereof an effective amount of a pharmaceutical composition...
52
5876757 Pharmaceutical composition for rapid thrombolytic therapy  
A magnesium-taurine compound and its method of synthesis. The compound is synthesized by reacting taurine and magnesium in a 2:1 molar ratio. The resulting mixture is diluted with methanol and the...
52
US20080194527 COMPOSITIONS AND COMBINATIONS 2  
Compositions and methods for preventing, inhibiting or treating a disorder associated with the loss of normal adult tissue architecture are provided.
52
US20040146498 Pharmaceutical combinations  
The present invention provides novel pharmaceutical combinations and their use in anti-thrombotic therapy. The combinations comprise a compound of formula (I) or a pharmaceutically acceptable...
52
US20060189584 Pharmaceutical combinations  
The present invention provides novel pharmaceutical combinations and their use in anti-thrombotic therapy. The combinations comprise a compound of formula (I) or a pharmaceutically acceptable...
52
US20080095741 R-(+)-alpha-liponic acid for the prevention of diabetes  
The invention relates to the use of R-(+)-α-lipoic acid in oxidised or reduced form or derivatives thereof alone or in combination with other effective compounds for the prevention of diabetes.
51
8217046 Cinnamoyl-piperazine derivatives and their use as PAR-1 antagonists  
The present invention relates to compounds of general formula (I): wherein: R1 represents: halogen, CN or NO2; R2 represents: hydrogen or halogen; n represents: 1 or 2; R3 represents: phenyl...
51
US20130064806 NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR  
The present invention provides for salts comprising a compound of Formula I and an acid that has activity against mammalian factor Xa. The present invention is also directed to methods of making...
51
US20050008688 Liposome drug delivery  
This invention comprises pharmaceutical compositions for administering a biologically active compound to an animal. Particularly provided are proliposomal compositions that are advantageously used...
51
US20180169077 PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR FIBROMYALGIA  
(1S)-2-acetyl-1-(4-chloro-2-methoxyphenyl)-5-fluoro-1,2,3,9- tetrahydrospiro[β-carboline-4,1′-cyclopropane] can significantly suppress a decrease of a pain threshold compared to well-known TSPO...
51
6416772 Topical dermal anaesthetic  
A liquid composition applied transdermally for relief of pain comprising alcohol in an amount by weight of about 57 to about 91 percent; glycerin in an amount by weight of about 1 to about 12...
51
US20020094343 TOPICAL DERMAL ANAESTHETIC  
A liquid composition applied transdermally for relief of pain comprising alcohol in an amount by weight of about 57 to about 91 percent; glycerin in an amount by weight of about 1 to about 12...
51
US20180036296 BENZAMIDES AND RELATED INHIBITORS OF FACTOR XA  
Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described....
51
10179124 Benzamides and related inhibitors of factor Xa  
Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described....
51
US20090239831 Compositions and methods for reducing hepatotoxicity associated with drug administration and treating non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and associated cirrhosis  
The present invention relates to the discovery that acetylsalicylic acid (ASA or aspirin), salicylic acid (SA) and related salicylate esters and their pharmaceutically acceptable salts, when...
51
7815904 Method of treating a pathological syndrome and a pharmaceutical agent  
A method of treating a pathological syndrome is disclosed, including administration of an activated form of ultra-low doses of antibodies to an antigen, which activated form is obtained by...
50
5007790 Sustained-release oral drug dosage form  
Sustained-release oral drug-dosage forms that release drug in solution at a rate controlled by the solubility of the drug are described. The dosage form comprises a tablet or capsule which...
50
9687551 Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity  
A novel pharmaceutical composition is provided by which nonsteroidal anti-inflammatory drugs (NSAIDs) are added directly to phospholipid-containing oil such as lecithin oils or to a bio-compatible...
50
6576274 Extracts of celery seed for the prevention and treatment of pain, inflammation and gastrointestinal irritation  
Biologically active extracts of celery seed are produced by controlled ethanolic extraction, distillation and drying, and further processing by supercritical fluid extractions (SFE), and may be...
50
5455027 Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon  
Copolymers of poly(alkylene oxides) and amino acids or peptide sequences are disclosed, which amino acids or peptide sequences have pendant functional groups that are capable of being conjugated...
50
US20140212486 ISOMETHEPTENE ISOMER  
The invention relates to a purified Isometheptene compound comprising the structure according to Formula (I), or a hydrochloride, or a pharmaceutically acceptable addition salt thereof. In...
50
US20020049183 Use of lipid conjugates in the treatment of disease  
The invention provides novel methods for treating disease based upon the medicinal use of lipids and phospholipids covalently bound to physiologically acceptable monomers or polymers....
50
4965065 Gastroprotective process and compositions  
A pharmaceutical composition and process for administering non-steroidal anti-inflammatory drugs which are protected against injury to gastrointestinal tract by beta adrenergic agonists.
50
US20100016262 Compositions and methods for reducing hepatotoxicity associated with drug administration and treating non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and associated cirrhosis  
The present invention relates to the discovery that acetylsalicylic acid (ASA or aspirin), salicylic acid (SA) and related salicylate esters and their pharmaceutically acceptable salts, when...
50
US20120115782 COMPOSITIONS AND METHODS FOR TREATING OR INHIBITING LIVER INJURY  
The present invention relates to the discovery that acetylsalicylic acid (ASA or aspirin), salicylic acid (SA) and related salicylate esters and their pharmaceutically acceptable salts, when...
50
6747003 Modified vitamin K-dependent polypeptides  
The invention provides vitamin K-dependent polypeptides with enhanced membrane binding affinity. These polypeptides can be used to modulate clot formation in mammals. Methods of modulating clot...
50
US20170301197 Emergency Responder Alert System  
A kit and a systematic method for alerting emergency responders of an exact location in which they have been dispatched. The system includes a container for holding medication, a strobe light and...
50
8070796 Thrombosis inhibiting graft  
A medical method that is adapted for introducing the medical device into the vascular system of a body which is designed to inhibit or prevent thrombosis after the insertion of the medical device.
49
5861399 Methods and compositions for the rapid and enduring relief of inadequate myocardial function  
Disclosed are methods and compositions for reducing coronary artery stenosis, restoring blood flow to infarcted myocardium, improving myocardial perfusion, reducing heart attacks or other adverse...
49
3894655 Plastic container  
An integrally formed, one-piece, generally rectangular, plastic container particularly adapted for holding medicines. The container includes a generally rectangular bottom section which is...
49


Search
« search again